Literature DB >> 27353028

Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development.

Allen Mo1, Stephen Jackson2, Kamini Varma2, Alan Carpino2, Charles Giardina3, Thomas J Devers4, Daniel W Rosenberg5.   

Abstract

UNLABELLED: Although the progression of mutated colonic cells is dependent upon interactions between the initiated epithelium and surrounding stroma, the nature of these interactions is poorly understood. Here, the development of an ultrasensitive laser capture microdissection (LCM)/RNA-seq approach for studying the epithelial and stromal compartments of aberrant crypt foci (ACF) is described. ACF are the earliest identifiable preneoplastic lesion found within the human colon and are detected using high-definition endoscopy with contrast dye spray. The current analysis focused on the epithelium of ACF with somatic mutations to either KRAS, BRAF, or APC, and expression patterns compared with normal mucosa from each patient. By comparing gene expression patterns among groups, an increase in a number of proinflammatory NF-κB target genes was identified that was specific to ACF epithelium, including TIMP1, RELA, and RELB Distinct transcriptional changes associated with each somatic mutation were observed and a subset of ACF display BRAF(V600E)-mediated senescence-associated transcriptome characterized by increased expression of CDKN2A Finally, LCM-captured ACF-associated stroma was found to be transcriptionally distinct from normal-appearing stroma, with an upregulation of genes related to immune cell infiltration and fibroblast activation. Immunofluorescence confirmed increased CD3(+) T cells within the stromal microenvironment of ACF and an abundance of activated fibroblasts. Collectively, these results provide new insight into the cellular interplay that occurs at the earliest stages of colonic neoplasia, highlighting the important role of NF-κB, activated stromal fibroblasts, and lymphocyte infiltration. IMPLICATIONS: Fibroblasts and immune cells in the stromal microenvironment play an important role during the earliest stages of colon carcinogenesis. Mol Cancer Res; 14(9); 795-804. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27353028      PMCID: PMC5025366          DOI: 10.1158/1541-7786.MCR-16-0156

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  50 in total

1.  Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression.

Authors:  Ermira Pazolli; Elise Alspach; Agnieszka Milczarek; Julie Prior; David Piwnica-Worms; Sheila A Stewart
Journal:  Cancer Res       Date:  2012-03-15       Impact factor: 12.701

2.  High levels of TIMP-2 correlate with adverse prognosis in breast cancer.

Authors:  A Remacle; K McCarthy; A Noël; T Maguire; E McDermott; N O'Higgins; J M Foidart; M J Duffy
Journal:  Int J Cancer       Date:  2000-03-20       Impact factor: 7.396

3.  BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status.

Authors:  Shi Yang; Francis A Farraye; Charline Mack; Oksana Posnik; Michael J O'Brien
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

Review 4.  Normalization of the tumor microenvironment: evidence for tissue inhibitor of metalloproteinase-2 as a cancer therapeutic.

Authors:  William G Stetler-Stevenson; Noah Veis Gavil
Journal:  Connect Tissue Res       Date:  2014 Jan-Feb       Impact factor: 3.417

Review 5.  Hallmarks of senescence in carcinogenesis and cancer therapy.

Authors:  Jerry W Shay; Igor B Roninson
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

Review 6.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

7.  Isolation of primary myofibroblasts from mouse and human colon tissue.

Authors:  Hassan Khalil; Wenxian Nie; Robert A Edwards; James Yoo
Journal:  J Vis Exp       Date:  2013-10-12       Impact factor: 1.355

8.  S-adenosylmethionine, a methyl donor, up regulates tissue inhibitor of metalloproteinase-2 in colorectal cancer.

Authors:  Z Hussain; M I Khan; M Shahid; F N Almajhdi
Journal:  Genet Mol Res       Date:  2013-04-10

9.  A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis.

Authors:  Mireia Berdiel-Acer; Daniel Cuadras; Natalia Guillén Díaz-Maroto; Xavier Sanjuan; Teresa Serrano; Antoni Berenguer; Victor Moreno; Samuel Gonçalves-Ribeiro; Ramon Salazar; Alberto Villanueva; David G Molleví
Journal:  Mol Cancer Res       Date:  2014-05-14       Impact factor: 5.852

10.  Gene expression profiling of the tumor microenvironment during breast cancer progression.

Authors:  Xiao-Jun Ma; Sonika Dahiya; Elizabeth Richardson; Mark Erlander; Dennis C Sgroi
Journal:  Breast Cancer Res       Date:  2009-02-02       Impact factor: 6.466

View more
  14 in total

1.  Methyl Donor Deficiency Blocks Colorectal Cancer Development by Affecting Key Metabolic Pathways.

Authors:  Matthew P Hanley; Oladimeji Aladelokun; Krishna Kadaveru; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2019-11-20

2.  Colon fibroblasts from Pirc rats (F344/NTac-Apcam1137 ) exhibit a proliferative and inflammatory phenotype that could support early stages of colon carcinogenesis.

Authors:  Katia Tortora; Francesca Margheri; Cristina Luceri; Alessandra Mocali; Sara Ristori; Lucia Magnelli; Giovanna Caderni; Lisa Giovannelli
Journal:  Int J Cancer       Date:  2021-09-18       Impact factor: 7.316

3.  The Epithelial-Stromal Microenvironment in Early Colonic Neoplasia.

Authors:  Takayasu Ideta; Boyang Li; Christopher Flynn; Yuichi Igarashi; Geoffrey Lowman; Tim Looney; Thomas J Devers; John Birk; Faripour Forouhar; Charles Giardina; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2021-10-20       Impact factor: 6.333

4.  Haploinsufficiency of Casitas B-Lineage Lymphoma Augments the Progression of Colon Cancer in the Background of Adenomatous Polyposis Coli Inactivation.

Authors:  Sean Richards; Joshua Walker; Masako Nakanishi; Mostafa Belghasem; Chimera Lyle; Nkiruka Arinze; Marc A Napoleon; Jonathan D Ravid; Nicholas Crossland; Qing Zhao; Daniel Rosenberg; Nader Rahimi; Vipul C Chitalia
Journal:  Am J Pathol       Date:  2020-02-26       Impact factor: 4.307

5.  Microscale Gene Expression Analysis of Tumor-Associated Macrophages.

Authors:  Kuldeep S Attri; Kamiya Mehla; Surendra K Shukla; Pankaj K Singh
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

6.  The Model-Based Study of the Effectiveness of Reporting Lists of Small Feature Sets Using RNA-Seq Data.

Authors:  Eunji Kim; Ivan Ivanov; Jianping Hua; Johanna W Lampe; Meredith Aj Hullar; Robert S Chapkin; Edward R Dougherty
Journal:  Cancer Inform       Date:  2017-06-12

7.  Use of the combination of the preoperative platelet-to-lymphocyte ratio and tumor characteristics to predict peritoneal metastasis in patients with gastric cancer.

Authors:  Xiao-Dong Chen; Chen-Chen Mao; Rui-Sen Wu; Wei-Teng Zhang; Ji Lin; Xiang-Wei Sun; Chu-Huai Chi; Neng Lou; Peng-Fei Wang; Xian Shen; Guan-Bao Zhu; Shu-Rong Shen
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

8.  Lysine-specific histone demethylase 1B (LSD2/KDM1B) represses p53 expression to promote proliferation and inhibit apoptosis in colorectal cancer through LSD2-mediated H3K4me2 demethylation.

Authors:  Shaoxin Cai; Jinsi Wang; Wei Zeng; Xuefei Cheng; Lihang Liu; Weihua Li
Journal:  Aging (Albany NY)       Date:  2020-07-29       Impact factor: 5.682

9.  Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.

Authors:  Isabel Quintanilla; María López-Cerón; Mireya Jimeno; Miriam Cuatrecasas; Michel Zabalza; Leticia Moreira; Virginia Alonso; Cristina Rodríguez de Miguel; Jennifer Muñoz; Sergi Castellvi-Bel; Josep Llach; Antoni Castells; Francesc Balaguer; Jordi Camps; Maria Pellisé
Journal:  Clin Transl Gastroenterol       Date:  2019-06       Impact factor: 4.488

10.  Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.

Authors:  Rebecca Carter; Azadeh Cheraghchi-Bashi; Adam Westhorpe; Sheng Yu; Yasmin Shanneik; Elena Seraia; Djamila Ouaret; Yasuhiro Inoue; Catherine Koch; Jenny Wilding; Daniel Ebner; Anderson J Ryan; Francesca M Buffa; Ricky A Sharma
Journal:  Cancer Biol Med       Date:  2019-05       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.